Browse the corpus

Amoxicillin is a widely utilized beta-lactam antimicrobial drug approved by the U.S. Food and Drug Administration (FDA) for use in the primary care setting. Amoxicillin is an aminopenicillin created by adding an extra amino group to penicillin to battle antibiotic resistance. This drug is indicated for the treatment of infections caused by susceptible isolates of selected bacteria, specifically those that are beta-lactamase–negative, including ear, nose, and throat infections, Helicobacter pylori eradication, lower respiratory and urinary tract infections, acute bacterial sinusitis, and skin and structure infections. Amoxicillin is effective against a wide range of gram-positive bacteria, offering additional coverage against some gram-negative organisms compared to penicillin. Amoxicillin's spectrum of activity includes coverage against Streptococcus species, with heightened efficacy against Listeria monocytogenes and Enterococcus spp. Furthermore, amoxicillin also demonstrates effectiveness against Haemophilus influenzae, select Escherichia coli strains, Actinomyces spp., Clostridium species, Salmonella spp., Shigella spp., and Corynebacteria spp. This activity delves into the indications, mechanism of action, administration, contraindications, and adverse event profiles associated with amoxicillin. This activity equips clinicians with a comprehensive understanding of amoxicillin to optimally enhance their ability to manage infectious diseases in patients. Objectives: Differentiate between the spectrum of activity of amoxicillin and other antimicrobial agents, understanding its coverage against various gram-positive and some gram-negative organisms compared to penicillin. Implement effective antimicrobial stewardship practices by selecting amoxicillin judiciously, considering its efficacy against specific bacteria causing the infection, and minimizing the risk of contributing to antimicrobial resistance. Select amoxicillin as a preferred agent for susceptible bacterial infections, considering its effectiveness against common pathogens and safety profile. Collaborate with other healthcare professionals to promote antimicrobial stewardship, enhancing outcomes and treatment efficacy for patients who might benefit from amoxicillin therapy. Access free multiple choice questions on this topic.

A prospective study of 51 pediatric patients at a poison control center suggested that amoxicillin overdoses of less than 250 mg/kg are not associated with significant clinical symptoms, as per the FDA product labeling. Signs and Symptoms of Overdose Interstitial nephritis leading to oliguric renal failure has been reported in a small number of patients following overdosage with amoxicillin.[23][24] Crystalluria leading to renal failure has been reported in both adult and pediatric patients following amoxicillin overdosage.[42] Management of Overdose In case of amoxicillin overdose, clinicians should discontinue amoxicillin therapy and provide supportive care to patients. Clinicians should maintain the patient's airway, breathing, and circulation. Healthcare providers should ensure the patient maintains adequate fluid intake to mitigate the risk of amoxicillin crystalluria. Renal impairment appears to be reversible with the cessation of drug administration. Amoxicillin may be removed from circulation by hemodialysis.[43][20] Individuals should contact a poison control center at 1-800-222-1222 for updated information about an amoxicillin overdose.

Amoxicillin is a commonly prescribed antimicrobial by nurse practitioners, primary care providers, and internists. Although amoxicillin is considered a safe drug, it is crucial to obtain a thorough history of allergies before prescribing the drug. Due to the widespread use of amoxicillin, healthcare providers should have a comprehensive understanding of its mechanism, resistance patterns, adverse drug reactions, and toxicity management.[39][44] Amoxicillin therapy is typically initiated by the clinician for the appropriate indication. However, a pharmacist must verify the dosing and duration, ensuring accuracy for the specific infection being treated. The pharmacist should also confirm that no drug interactions could impede the treatment's effectiveness. The nursing staff can provide counseling on administration and verify adherence. In addition, nurses should educate patients not to discontinue amoxicillin when they feel better. If the nurse or pharmacist encounters any issues, they should promptly address them with the prescriber. In case of a significant overdose, triage nurses should admit the patient. Emergency physicians are responsible for evaluating and managing nephrotoxicity. Nephrologist consultation becomes necessary for hemodialysis. Consultation with a medical toxicologist or poison control center is recommended for the latest information.[45] Infectious disease specialists play a crucial role in ensuring the proper management of pseudomembranous colitis resulting from inappropriate amoxicillin use. In addition, they should emphasize the importance of antimicrobial stewardship—a coordinated program that promotes the appropriate use of antimicrobials, improves patient outcomes, diminishes microbial resistance, and mitigates the spread of infections caused by multidrug-resistant organisms.[46] As illustrated above, clinicians (MDs, DOs, NPs, PAs), specialists, pharmacists, nurses, and other healthcare providers should collaborate to maximize the efficacy and minimize adverse drug reactions related to amoxicillin therapy. This interprofessional team approach and antimicrobial stewardship will enhance the likelihood of more favorable patient outcomes.[47]